Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like FY25 Preliminary Results Summary and Company Update August 29, 2025 How to Invest in Rare Earth Metals May 6, 2025 Top 5 Canadian Mining Stocks This Week: Avanti... July 12, 2025 Golconda Gold September 30, 2025 Canadian Wildfires Force Mining Sector to Retreat as... June 3, 2025 Peter Grandich: Copper, Uranium in “Perfect Storm,” My... July 29, 2025 Jeffrey Christian: Gold, Silver, PGMs — Short-term Prices... June 21, 2025 Questcorp Mining Receives Permit Exemption for IP Survey... September 3, 2025 Cizzle Brands Expands Availability of CWENCH Hydration at... April 17, 2025 Strategic EL Secured -Expands Control of NSW Silver... August 13, 2025